NCT07587723
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Novartis Basel, Switzerland
Clinical trial condition
Hemorrhagic Disorders
Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.
4,576 public trials
831 recruiting studies
Hemorrhagic Disorders trial results
NCT07116616
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
- UCSF San Francisco, California, United States
- Emory University Hospital Atlanta, Georgia, United States
- Mass General Brigham Boston, Massachusetts, United States
Recruiting
18F-Fluciclovine PET/CT in Multiple Myeloma
NCT06103838
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®)
NCT07723560
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Unité d'Hémostase Clinique Centre Régional de Traitement des Hémophiles Centre de Référence de Maladies Hémorragiques Hôpital Cardiologique Louis Pradel Bron, France
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- City of Hope Irvine Lennar Irvine, California, United States
- University of Miami Miami, Florida, United States
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
NCT05006716
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- Mayo Clinic Phoenix Phoenix, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
NCT06910670
- Conditions
- Adenocarcinoma, Blood Protein Disorders, Carcinoma, +27 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT07104565
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Palo Verde Cancer Specialists Palo Verde Hematology Oncology, Ltd Glendale Glendale, Arizona, United States
- Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
- Rocky Mountain Cancer Centers Lone Tree, Colorado, United States
- Yale University School of Medicine New Haven, Connecticut, United States
NCT07429721
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Union Hospital, Huazhong University of Science and Technology Wuhan, Hubei, China